{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:04:14Z","timestamp":1785135854633,"version":"3.55.0"},"reference-count":11,"publisher":"The Korean Association for the Study of the Liver","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["e-cmh.org"],"crossmark-restriction":true},"short-container-title":["Clin Mol Hepatol"],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.3350\/cmh.2026.0123","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:22:00Z","timestamp":1770337320000},"page":"e434-e436","update-policy":"https:\/\/doi.org\/10.3350\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to correspondence on \u201cComparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis\u201d"],"prefix":"10.3350","volume":"32","author":[{"given":"Yang-Hsiang","family":"Lin","sequence":"first","affiliation":[{"name":"Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chih","family":"Hu","sequence":"additional","affiliation":[{"name":"Liver Research Unit, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1225-3895","authenticated-orcid":true,"given":"Chih-Lang","family":"Lin","sequence":"additional","affiliation":[{"name":"Liver Research Unit, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan"},{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Community Medicine Research Center, Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan"},{"name":"Department of Gastroenterology and Hepatology, Jen-Ai Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1902","reference":[{"key":"ref1","first-page":"305","type":"journal-article","volume-title":"Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis","author":"Choi","year":"2026"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2026.0002","type":"journal-article"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2025.0960","type":"journal-article"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001417","type":"journal-article"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2021.0383","type":"journal-article"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.49856","type":"journal-article"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332687","type":"journal-article"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101557","type":"journal-article"},{"key":"ref9","first-page":"e70447","type":"journal-article","volume-title":"GLP-1RA and liver fibrosis progression in MASLD and type 2 diabetes: target trial emulation using propensity score matching","author":"Choi","year":"2025"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101624","type":"journal-article"},{"key":"ref11","first-page":"e372","type":"journal-article","volume-title":"Correspondence to editorial on \u201cComparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs","author":"Choi","year":"2026"}],"container-title":["Clinical and Molecular Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2026-0123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2026.0123","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2026-0123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:48:52Z","timestamp":1785134932000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2026.0123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.3350\/cmh.2026.0123","relation":{},"ISSN":["2287-2728","2287-285X"],"issn-type":[{"value":"2287-2728","type":"print"},{"value":"2287-285X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"2026-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-05","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}